Results 271 to 280 of about 631,529 (311)
Some of the next articles are maybe not open access.

Molecular Targeting of Lymphatics for Therapy

Current Pharmaceutical Design, 2004
The dysfunction or proliferation of lymphatic vessels (lymphangiogenesis) is linked to a number of pathological conditions including lymphedema and cancer. The recent discovery and characterisation of the lymphangiogenic growth factors vascular endothelial growth factor-C (VEGF-C) and VEGF-D and of their receptor on lymphatic endothelial cells, VEGFR-3,
S A, Stacker, R A, Hughes, M G, Achen
openaire   +2 more sources

Targeted Molecular Therapy in Melanoma

Seminars in Cutaneous Medicine and Surgery, 2010
Immunotherapy and chemotherapy benefit few patients with metastatic melanoma, and even fewer experience durable survival benefit. These poor results may come from treating all melanomas as though they are biologically homogeneous. Recently, it has been shown that targeting specific activated tyrosine kinases (oncogenes) can have striking clinical ...
Igor, Puzanov, Keith T, Flaherty
openaire   +2 more sources

Molecular Targets of Antiviral Therapy

New England Journal of Medicine, 1989
THE development of specific antiviral drugs that are minimally toxic to normal cells has ushered in a new era of antiviral therapy.
Jeffrey S. Flier   +2 more
openaire   +2 more sources

Molecular Targets and Targeted Therapies for Malignant Mesothelioma

Current Medicinal Chemistry, 2008
Malignant mesothelioma is a highly invasive tumor originating from the mesothelial linings of the pleura, peritoneum and pericardium. It is seldom amenable to surgical intervention and poorly responsive to radiotherapy, leaving chemotherapy as the main therapeutic option for most patients. The development of effective drug regimens against mesothelioma
PALUMBO, CAMILLA   +3 more
openaire   +3 more sources

Molecular targets in cancer therapy

Seminars in Oncology Nursing, 2003
To review selected pharmacologic agents that target key cellular processes along with their mechanisms of action and adverse events. Nursing implications including what patients and families need to know, administration issues, and management of common toxicities will be reviewed.Research articles, clinical trials, abstracts, and book chapters ...
openaire   +2 more sources

Principles of Molecular Targeting for Radionuclide Therapy

2022
Molecular targeting requires assessing several factors that come into play such as the location of the target, the choice of radionuclide, the inertness of the bifunctional chelate and stability of the covalently bound halogens, matching the residence time in the tumor with the physical half-life of the radionuclide, the scale and scope of the disease,
Francesco Bartoli   +4 more
openaire   +3 more sources

Targeted Molecular Therapy

2019
The treatment of advanced thyroid cancer has developed with increased understanding of the molecular basis of the disease. Alongside this targeted therapies have been developed, and there is evidence of efficacy for multikinase inhibitors in improving progression-free survival in this population of patients.
Arabella Hunt, Kate L. Newbold
openaire   +1 more source

Targeted molecular therapy of malignant gliomas

Current Neurology and Neuroscience Reports, 2005
Malignant gliomas are the most common form of primary brain tumors in adults. Despite advances in diagnosis and standard therapies such as surgery, radiation, and chemotherapy, the prognosis remains poor. Recent scientific advances have enhanced our understanding of the biology of gliomas and the role of tyrosine kinase receptors and signal ...
Santosh, Kesari   +4 more
openaire   +3 more sources

Targets for molecular therapy of skin cancer

Seminars in Cancer Biology, 2004
Cancers of the skin encompass the first and second most common neoplasms in the United States, epidermal basal cell carcinoma (BCC) and squamous cell carcinoma (SCC), respectively, as well as the melanocytic malignancy, malignant melanoma (MM). Recently identified alterations in the function of specific genes in these cancers provide new potential ...
Cheryl L, Green, Paul A, Khavari
openaire   +2 more sources

Molecular Targets for Cancer Therapy and Prevention

Chest, 2004
Despite major improvements in patient management, the prognosis for patients with lung cancer remains dismal. As our knowledge of the molecular biology of cancers has increased, new targets for therapeutic interventions have been identified. In this article, we discuss some of the more recent developments in this field.
Adi F, Gazdar   +7 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy